Back
Open Access

Introduction and a clinical case of a patient with HFrEF

Session: Tackling the risk of hyperkalaemia through guideline-recommended heart failure therapy
Topic: Chronic Heart Failure
Speaker: Doctor M. Kosiborod (Kansas City, US)
Sponsored by PACE-CME - Supported by an unrestricted educational grant from AstraZeneca
Event: ESC Congress 2023

Congress Presentation

Add to my library

Like

About the speaker

Doctor Mikhail Kosiborod

St. Luke's Mid America Heart Institute, Kansas City (United States of America)
55 presentations
10 followers

4 more presentations in this session

The key role of RAASi-based therapy in symptomatic heart failure

Speaker: Doctor S. Zieroth (Winnipeg, CA)

Access
Slides
Video
Like
Thumbnail

Clinical choices in tackling the risk of hyperkalaemia

Speaker: Doctor M. Kosiborod (Kansas City, US) Doctor S. Zieroth (Winnipeg, CA) Doctor A. Wong (Bridgend, GB)

Access
Slides
Video
Like
Thumbnail

A practical model for optimising RAASi-based therapy

Speaker: Doctor A. Wong (Bridgend, GB)

Access
Slides
Video
Like
Thumbnail

Summary and conclusions

Speaker: Doctor M. Kosiborod (Kansas City, US)

Access
Slides
Video
Like
Thumbnail

Access the full session

Tackling the risk of hyperkalaemia through guideline-recommended heart failure therapy

Speakers: Doctor M. Kosiborod, Doctor S. Zieroth, Doctor M. Kosiborod, Doctor S. Zieroth, Doctor A. Wong...
Access
Video
Like
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources